Shopping Cart
- Remove All
 Your shopping cart is currently empty Your shopping cart is currently empty
TTP-8307 is an antiviral compound that inhibits the replication of rhinoviruses and enteroviruses, and inhibits coxsackievirus B3 and poliovirus by interfering with viral RNA synthesis.TTP-8307 can be used in the study of viral infections.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 1 mg | $107 | In Stock | |
| 5 mg | $263 | In Stock | |
| 10 mg | $423 | In Stock | |
| 25 mg | $822 | In Stock | |
| 50 mg | $1,230 | In Stock | |
| 100 mg | $1,990 | In Stock | |
| 200 mg | $2,680 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $318 | In Stock | 
| Description | TTP-8307 is an antiviral compound that inhibits the replication of rhinoviruses and enteroviruses, and inhibits coxsackievirus B3 and poliovirus by interfering with viral RNA synthesis.TTP-8307 can be used in the study of viral infections. | 
| Targets&IC50 |  Sabin poliovirus:0.85 μM (EC50), CVB3 Nancy:1.2 μM (EC50), Enteroviruses A16 and A21:5.34 μM (EC50) | 
| In vitro | TTP-8307 targeted non-structural protein 3A and inhibited the replication of enterovirus B3 (CVB3 Nancy) with an EC50 of 1.2 μM. In addition, TTP-8307 inhibited the replication of three Sabin poliovirus strains, as well as enteroviruses A16 and A21, with EC50s of 0.85 and 5.34 μM, respectively.Meanwhile, TTP-8307 inhibited the replication of human rhinoviruses (HRVs) 2, 29, 39, 45, 63 and 85 was also inhibitory. Mutations in non-structural protein 3A caused resistance to TTP-8307, a novel enterovirus replication inhibitor. In addition, TTP-8307 inhibits OSBP-dependent viruses, including encephalomyelitis virus (EMCV) and hepatitis C virus (HCV). [1][2] | 
| Synonyms | TTP8307 | 
| Molecular Weight | 436.48 | 
| Formula | C27H21FN4O | 
| Cas No. | 950225-08-8 | 
| Smiles | C(N[C@H](C)C1=CC=C(F)C=C1)(=O)C=2C=C(C=3NC(=NC3)C4=CC5=C(C=N4)C=CC=C5)C=CC2 | 
| Relative Density. | no data available | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (183.28 mM), Sonication is recommended.  | |||||||||||||||||||||||||||||||||||
| Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
| DMSO 
 | ||||||||||||||||||||||||||||||||||||
 For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL .
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL .  A total of 10 animals were administered, and the formula you used is 5%
 A total of 10 animals were administered, and the formula you used is 5%  DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。 (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
 (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first. main solution, add 300 μLPEG300
 main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O
 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
 mix well and clarify
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.